STOCK TITAN
  1. Home
  2. Sec-filings
  3. COCO
  4. [Form 4] Vita Coco Company, Inc. Insider Trading Activity

Vita Coco CEO reports insider sales; updated holdings disclosed

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Vita Coco (COCO) CEO and Director Martin Roper filed a Form 4 reporting open-market sales of common stock on 10/29/2025 and 10/30/2025 made under a Rule 10b5-1 trading plan.

Direct transactions included 5,000 shares at a weighted average price of $46.087 on 10/29 and 500 shares at $45.00 on 10/30. Indirect transactions included 5,000 shares at a weighted average $46.108 on 10/29 and 500 shares at $45.00 on 10/30 by the Christopher G. Roper Exempt Family Trust, plus 5,000 shares each on 10/29 by the Peter S. Roper and Thomas L. Roper Exempt Family Trusts at weighted average prices within the disclosed ranges.

Following these transactions, reported beneficial holdings were 281,562 shares (direct), 215,631 (Christopher G. Roper Exempt Family Trust), 216,131 (Peter S. Roper Exempt Family Trust), 216,131 (Thomas L. Roper Exempt Family Trust), and 61,200 (by spouse).

Positive

  • None.

Negative

  • None.
Insider Roper Martin
Role Chief Executive Officer
Sold 21,000 shs ($967K)
Type Security Shares Price Value
Sale Common Stock 500 $45.00 $23K
Sale Common Stock 500 $45.00 $23K
Sale Common Stock 5,000 $46.087 $230K
Sale Common Stock 5,000 $46.108 $231K
Sale Common Stock 5,000 $46.036 $230K
Sale Common Stock 5,000 $46.151 $231K
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 281,562 shares (Direct); Common Stock — 215,631 shares (Indirect, by Chris Roper FT); Non-Qualified Stock Option (right to buy) — 579,670 shares (Direct)
Footnotes (1)
  1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $48.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $48.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Christopher G. Roper Exempt Family Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $48.48, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Peter S. Roper Exempt Family Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $48.50, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Thomas L. Roper Exempt Family Trust. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Roper Martin
(Last) (First) (Middle)
111 5TH AVENUE
2ND FLOOR
(Street)
NEW YORK NY 10003
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/29/2025 S(1) 5,000 D $46.087(2) 282,062 D
Common Stock 10/30/2025 S(1) 500 D $45 281,562 D
Common Stock 10/29/2025 S(1) 5,000 D $46.108(3) 216,131 I by Chris Roper FT(4)
Common Stock 10/30/2025 S(1) 500 D $45 215,631 I by Chris Roper FT(4)
Common Stock 10/29/2025 S(1) 5,000 D $46.036(5) 216,131 I by Peter Roper FT(6)
Common Stock 10/29/2025 S(1) 5,000 D $46.151(7) 216,131 I by Thomas Roper FT(8)
Common Stock 61,200 I by Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $10.178 (9) 09/19/2029 Common Stock 579,670 579,670 D
Non-Qualified Stock Option (right to buy) $10.178 (10) 01/11/2031 Common Stock 40,950 40,950 D
Non-Qualified Stock Option (right to buy) $15 (11) 10/21/2031 Common Stock 298,507 298,507 D
Non-Qualified Stock Option (right to buy) $16.91 (12) 03/10/2033 Common Stock 46,875 46,875 D
Non-Qualified Stock Option (right to buy) $26.18 (13) 03/04/2034 Common Stock 62,743 62,743 D
Non-Qualified Stock Option (right to buy) $32.78 (14) 03/03/2035 Common Stock 70,715 70,715 D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $48.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $48.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
4. These shares are held by the Christopher G. Roper Exempt Family Trust.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $48.48, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
6. These shares are held by the Peter S. Roper Exempt Family Trust.
7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $48.50, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
8. These shares are held by the Thomas L. Roper Exempt Family Trust.
9. The stock option is fully vested and currently exercisable.
10. The stock option is fully vested and currently exercisable.
11. The stock option vests in four equal annual installments beginning on November 27, 2022.
12. The stock option vests in four equal annual installments beginning on March 10, 2024.
13. The stock option vests in four equal annual installments beginning on March 4, 2025.
14. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
By: Alison Klein, Attorney-in-Fact For: Martin Roper 10/31/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did COCO’s CEO report on Form 4?

Martin Roper reported open-market sales of common stock on 10/29/2025 and 10/30/2025 executed under a Rule 10b5-1 trading plan.

How many COCO shares did the CEO sell directly and at what prices?

Direct sales were 5,000 shares at a weighted average $46.087 on 10/29 and 500 shares at $45.00 on 10/30.

Were there indirect sales reported for COCO?

Yes. The Christopher G. Roper Exempt Family Trust sold 5,000 shares at a weighted average $46.108 on 10/29 and 500 shares at $45.00 on 10/30; the Peter S. Roper and Thomas L. Roper Exempt Family Trusts each sold 5,000 shares on 10/29 at weighted average prices within the filing’s ranges.

What shareholdings did the Form 4 show after the transactions?

Post-transaction holdings were 281,562 (direct), 215,631 (Christopher G. Roper Exempt Family Trust), 216,131 (Peter S. Roper Exempt Family Trust), 216,131 (Thomas L. Roper Exempt Family Trust), and 61,200 (by spouse).

What price ranges did COCO shares trade at in these sales?

Weighted average prices reflect multiple trades within ranges: $45.00–$48.00, $45.00–$48.48, and $45.00–$48.50, as noted in the footnotes.

What COCO stock options were reported as beneficially owned?

Reported non-qualified stock options include: 579,670 at $10.178 expiring 09/19/2029; 40,950 at $10.178 expiring 01/11/2031; 298,507 at $15.00 expiring 10/21/2031; plus later grants at $16.91, $26.18, and $32.78 with stated vesting schedules.